Skip to the page

Data / Form D filings / AnchorTherapeutics, Inc

AnchorTherapeutics, Inc: Form D filings

AnchorTherapeutics, Inc, a company in Cambridge, MA, filed 2 Form D notices with the SEC between 2009 and 2010. The latest, on August 23, 2010, reports $5 million sold of a $15 million offering to 4 investors.

Find out what AnchorTherapeutics, Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
67 ROGERS STREET, Cambridge, MA, 02142
Phone
(508) 545-2590
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2006
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506
SEC identifier (CIK)
1417010

The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in other industries: 9,873 rows, $178.73, or the new rows each week for $19.10 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 23, 2010New notice$15,000,000$5,000,000$10,000,0004Aug 19, 2010sec.gov
May 27, 2009Amendment$18,999,997$18,999,997$04Oct 15, 2007sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Robert K. KamenDirector
Stephen K. HuntExecutive Officer
Thomas K. McMurryExecutive Officer
Christopher K. MirabelliDirector
Jnes EcksteinDirector
Michael K. WebbDirector
Frederick Jones, III, M.D., MBAExecutive Officer, Director
Lauren K. SilvermanDirector

Other companies in Massachusetts that filed recently

Every Form D from the week of Aug 23, 2010 · All recent filings in Massachusetts · All recent Other filings

Read from SEC EDGAR. Amount sold is what AnchorTherapeutics, Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.